Top news of the week: 22.09.2020.
Pharmacology, Biotechnology, Clinical trial, Medicine, Radiography, Disease
Healthcare
Congratulations to all involved here - science in action. #InnovateForLife @inflazome @RocheIrl
https://t.co/4JliMxNaJf
OpenSwiss drug giant Roche pays €380m for Irish biotech Inflazome
Company hunting for medicines to to tackle chronic inflammatory conditions likes Alzheimer’s
RT @MarcJacksonLA: $HCM How This Nasdaq-U.K.-Listed Chinese Biotech Is Revolutionizing Cancer Treatment https://t.co/fbeka936ny via @Barronsonline
OpenHow This Nasdaq-U.K.-Listed Chinese Biotech Is Revolutionizing Cancer Treatment
Chi-Med has been granted three U.S. Food and Drug Administration Fast Track Designations for its cancer drugs.
3 Biotech Stocks That Surged Last Week #BioTech via https://t.co/2sI0UxJbpn https://t.co/RMgIiwzj7p
Open3 Biotech Stocks That Surged Last Week
Find out what's behind their big run-ups to see if they can make it happen again.
Moderna and Pfizer’s Vaccine Transparency, Gilead’s Megadeal and a Tribute to Bill Sr.
Before diving into a big week in biotech, let’s pause to think about the life of a tremendous human being we can learn from. RIP Bill Gates Sr. died at age 94. He had Alzheimer’s. The ...
RT @yhn: Huntsville biotech company that aims to increase diversity in clinical trials receives investment https://t.co/CHS7SWo6bB
OpenHuntsville biotech company that aims to increase diversity in clinical trials receives investment
Acclinate Genetics in Huntsville received this week an investment from Birmingham venture capital firm Bronze Valley. The investment will help
RT @BIVnews: COVID-19 treatment linked to B.C. biotech shows signs of reducing hospitalizations
https://t.co/bw8WfGxeGR https://t.co/MMORgbZCDj
OpenCOVID-19 treatment linked to B.C. biotech shows signs of reducing hospitalizations
What happened: COVID-19 treatment developed in part by a Vancouver company is showing signs of reducing hospitalizations
Forma Therapeutics nabs new R&D execs as it plots late-stage sickle cell test next year https://t.co/nq86Mm1EiS
OpenForma Therapeutics nabs new R&D execs as it plots late-stage sickle cell test next year
Heading into a pivotal year in 2021, Forma Therapeutics has hired two veterans out of Takeda and Incyte to help run its R&D programs.